Skip to main content

Table 1 Summary of patients with aneurysmal subarachnoid hemorrhage during or after COVID-19

From: Persistent intracranial hyper-inflammation in ruptured cerebral aneurysm after COVID-19: case report and review of the literature

No

Patient

Age (years)

Sex

COVID-19

SAH

Severitya

Comorbidities

Duration (day)b

Signs at onset

Outcome

Reference

1

Ref12-1

13

Female

Severe

None

0

LOC

Severe disability

12

2

Ref13-1

NA (adult)

NA

NA

NA

3

NA

NA

13

3

Ref13-2

NA (adult)

NA

NA

NA

NA

NA

NA

4

Ref13-3

NA (adult)

NA

NA

NA

9

NA

NA

5

Ref16-1

31

Male

Mild

None

0

Headache, LOC

NA

16

6

Ref15-1

36

Female

Moderate

NA

1

Headache, LOC

Moderate disability

15

7

Ref14-1

60

Female

Severe

NA

0

LOC

NA

14

8

Ref9-1 to 10

 < 30: 1

30–40: 5

40–50: 2

 > 50: 2

Male: 5

Female: 5

Asymptomatic: 2

Mild: 2

Moderate: 1

Severe: 3

Hypertension: 1

0

NA

Good recovery: 7

Moderate disability: 1

Severe disability or death: 2

9

9

10

11

12

13

14

15

16

17

18

Ref7-1

52

Male

Mild

Hypertension

0

LOC

Good recovery

7

19

Ref7-2

61

Male

Asymptomatic

Hypertension

14

LOC

NA

20

Ref8-1

61

Female

Moderate

Hypertension, overweight

1

Headache, LOC

Good recovery

8

21

Ref17-1

68

Female

Asymptomatic

Previous aneurysm

0

Headache, vomiting

Good recovery

17

22

Ref18-1

58

Female

Severe

Colon cancer

21

LOC

Good recovery

18

23

Present

10

Male

Mild

None

14

LOC, seizure

Death

This study

  1. SAH subarachnoid hemorrhage, NA not available, LOC loss of consciousness
  2. aSeverity represents respiratory distress syndrome with systemic involvement (severe), pneumonia with or without respiratory support (moderate) and mild respiratory symptoms or fever alone (mild)
  3. bEach value indicates the duration from the diagnosis of symptomatic or asymptomatic SARS-CoV-2 infection to the onset of SAH